Christopher R Moyes

This inventor holds 7 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Kallyope, Inc.. Active years: 2013-2025.

USPTO Granted Patents = 7 (Patent Applications = 5)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 19(Granted Patents)

Location History:

Westfiled, NJ (US) (2021)
Westfield, NJ (US) (2013 - 2022)

Company Filing History:

5 out of 2,405

Merck Sharp + Dohme Corp.

Years Active: 2013-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12281114 - NK3 modulators and uses thereof (2025-04-21),

2. 11512065 - GPR119 agonists (2022-11-29),

3. 11041009 - Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes (2021-06-22),

4. 9884125 - Glucose-responsive insulin conjugates (2018-02-06),

5. 9006228 - Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment (2015-04-14),

6. 8604038 - Pyrrolidine derived beta 3 adrenergic receptor agonists (2013-12-10),

7. 8354403 - Pyrrolidine derived beta 3 adrenergic receptor agonists (2013-01-15),

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents. Would you like me to assist with this?

Profile summary based on public USPTO records.